Similar articles

• Lymphocytes in children treated with phenytoin.

  Seager J. Seager J. Lancet. 1976 Nov 27;2(7996):1205. doi: 10.1016/s0140-6736(76)91724-4. Lancet. 1976. PMID: 63034 No abstract available.
• Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.

  Higashi A, Matsuda I, Sinosuka S, Ohtsuka H, Endo F, Maeda T, Ikeda T, Miyoshino S. Higashi A, et al. Eur J Pediatr. 1978 Dec 1;129(4):273-8. doi: 10.1007/BF00441358. Eur J Pediatr. 1978. PMID: 152707
• Serum IgA deficiency induced by prolonged phenytoin treatment.

  Talesnik E, Rivero SJ, González B. Talesnik E, et al. Rev Invest Clin. 1989 Oct-Dec;41(4):331-5. Rev Invest Clin. 1989. PMID: 2631168
• Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.

  Gilhus NE, Matre R, Aarli JA. Gilhus NE, et al. Int J Immunopharmacol. 1982;4(1):43-8. doi: 10.1016/0192-0561(82)90007-8. Int J Immunopharmacol. 1982. PMID: 6979523
• New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

  Bebin M, Bleck TP. Bebin M, et al. Drugs. 1994 Aug;48(2):153-71. doi: 10.2165/00003495-199448020-00003. Drugs. 1994. PMID: 7527321 Review.